Videx Ec

The recommended adult dose of didanosine is based on body weight. People weighing 60 kg and over should be taking 400 mg once daily. People weighing less than 60 kg should be taking 250 mg once daily.

Many things can affect the dose of medication that a person needs, such as body weight, other medical conditions, and other medications. If your doctor has recommended a dose different from the ones listed here, do not change the way that you are taking the medication without consulting your doctor.

Didanosine should be taken on an empty stomach (at least 1.5 hours before or 2 hours after eating) since food appears to reduce the amount of medication that gets absorbed into the bloodstream. It should not be taken with acidic fruit juices, as the acid in these juices can reduce the amount of medication available to be absorbed by the body.

Videx Ec should be swallowed whole, not chewed or crushed.

It is important to take Videx Ec exactly as prescribed by your doctor. If you miss a dose, take it as soon as possible and continue with your regular schedule. If it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one. If you are not sure what to do after missing a dose, contact your doctor or pharmacist for advice.

Store Videx Ec in its original container, at room temperature, away from heat, direct light, and moisture. Keep it out of the reach of children.

Do not dispose of medications in wastewater (e.g. down the sink or in the toilet) or in household garbage. Ask your pharmacist how to dispose of medications that are no longer needed or have expired.

Videx® chewable tablets and pediatric solution are no longer available in Canada.

125 mg
Each white, opaque, enteric-coated beadlet capsule, printed in tan with "BMS 125 mg" and "6671", contains 125 mg of didanosine. Nonmedicinal ingredients: carboxymethylcellulose sodium, diethyl phthalate, methacrylic acid copolymer, sodium hydroxide, sodium starch glycolate, and talc; capsule shell: gelatin, sodium lauryl sulfate, and titanium dioxide. Capsules are imprinted with edible ink.

200 mg
Each white, opaque, enteric-coated beadlet capsule, printed in green with "BMS 200 mg" and "6672", contains 200 mg of didanosine. Nonmedicinal ingredients: carboxymethylcellulose sodium, diethyl phthalate, methacrylic acid copolymer, sodium hydroxide, sodium starch glycolate, and talc; capsule shell: gelatin, sodium lauryl sulfate, and titanium dioxide. Capsules are imprinted with edible ink.

250 mg
Each white, opaque, enteric-coated beadlet capsule, printed in blue with "BMS 250 mg" and "6673", contains 250 mg of didanosine. Nonmedicinal ingredients: carboxymethylcellulose sodium, diethyl phthalate, methacrylic acid copolymer, sodium hydroxide, sodium starch glycolate, and talc; capsule shell: gelatin, sodium lauryl sulfate, and titanium dioxide. Capsules are imprinted with edible ink.

400 mg
Each white, opaque, enteric-coated beadlet capsule, printed in red with "BMS 400 mg" and "6674", contains 400 mg of didanosine. Nonmedicinal ingredients: carboxymethylcellulose sodium, diethyl phthalate, methacrylic acid copolymer, sodium hydroxide, sodium starch glycolate, and talc; capsule shell: gelatin, sodium lauryl sulfate, and titanium dioxide. Capsules are imprinted with edible ink.

Do not take didanosine if you are allergic to didanosine or any ingredient of the medication.

There may be an interaction between didanosine and any of the following:

• alcohol
• Allopurinol
• atazanavir
• "azole" antifungals (e.g., fluconazole, itraconazole, ketoconazole)
• darunavir
• Febuxostat
• Ganciclovir
• Hydroxyurea
• indinavir
• lopinavir
• Methadone
• quinolone antibiotics (e.g., ciprofloxacin, moxifloxacin, Norfloxacin)
• ribavirin
• rilpivirine
• stavudine
• tenofovir
• tipranavir
• valganciclovir

If you are taking any of these medications, speak with your doctor or pharmacist. Depending on your specific circumstances, your doctor may want you to:

• stop taking one of the medications,
• change one of the medications to another,
• change how you are taking one or both of the medications, or
• leave everything as is.

An interaction between two medications does not always mean that you must stop taking one of them. Speak to your doctor about how any drug interactions are being managed or should be managed.

Medications other than those listed above may interact with Videx Ec. Tell your doctor or prescriber about all prescription, over-the-counter (non-prescription), and herbal medications you are taking. Also tell them about any supplements you take. Since caffeine, alcohol, the Nicotine from cigarettes, or street drugs can affect the action of many medications, you should let your prescriber know if you use them.

Before you begin taking a medication, be sure to inform your doctor of any medical conditions or Allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should take Videx Ec.

Fat redistribution: Over time, Videx Ec may change how fat is distributed in your body and may change your body shape. You may notice increased fat in the upper back and neck, breast, around the back, chest, and stomach area; or loss of fat from the legs, arms, and face. The long-term effects of this are not known.

Immune reconstitution syndrome: Videx Ec may cause immune reconstitution syndrome, where signs and symptoms of inflammation from previous infections appear. These symptoms occur soon after starting anti-HIV medication and can vary. They are thought to occur as a result of the immune system improving and being able to fight infections that have been present without symptoms (such as pneumonia, herpes, or Tuberculosis). Report any new symptoms to your doctor as soon as possible.

Kidney function: Didanosine is removed from the body by the kidneys. Decreased kidney function may cause an increase in side effects due to an increased amount of medication in the body.

If you have reduced kidney function, discuss with your doctor how Videx Ec may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Videx Ec, and whether any special monitoring is needed. People with severely reduced kidney function should not take Videx Ec.

Lactic acidosis and enlarged fatty liver: Didanosine can cause a rare but serious condition called lactic acidosis (build-up of lactic acid in the blood) together with an enlarged liver. This tends to occur more often in women, especially if they are overweight. If you experience any of the following symptoms, call your doctor immediately:

• abdominal pain, swelling, or bloating
• diarrhea
• fatigue
• feeling unwell
• nausea
• shortness of breath
• vomiting
• weakness
• weight loss

Your doctor will monitor your liver function periodically by ordering laboratory tests.

Liver function: People with liver disease or reduced liver function appear to have an increased risk of additional liver damage due to taking didanosine. If you have liver disease or decreased liver function, discuss with your doctor how Videx Ec may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Videx Ec, and whether any special monitoring is needed.

Liver failure has occurred in people taking didanosine who have had no previous liver problems. If you experience symptoms of liver problems (e.g., abdominal pain, persistent vomiting, feeling unwell, fever, itching, yellowing of the skin and eyes, dark urine), contact your doctor immediately.

Pancreatitis (inflammation of the pancreas): Didanosine may cause or worsen pancreatitis. If you have a history of or are at risk for developing pancreatitis, you should be closely monitored by your doctor while taking Videx Ec. If you develop signs of pancreatitis (e.g., upper left abdominal pain, back pain, nausea, fever, chills, rapid heartbeat, swollen abdomen), contact your doctor.

Peripheral Neuropathy: Didanosine may cause numbness, tingling or pain in the feet or hands. This is known as peripheral neuropathy, a nervous system complication of both the disease and Videx Ec. If you experience these symptoms, contact your doctor as soon as possible.

Portal hypertension: Portal hypertension (increased blood pressure in the large vein of the liver) may occur with normal use of didanosine. Your doctor will order blood tests to check for early signs of this complication. If you experience vomiting blood or an unusual increase in the size of your abdomen, contact your doctor as soon as possible.

Pregnancy: There have been reports of birth defects in babies born to mothers who took Videx Ec while pregnant. Videx Ec should not be used during pregnancy unless the benefits outweigh the risks. If you become pregnant while taking Videx Ec, contact your doctor immediately.

Breast-feeding: It is not known if didanosine passes into breast milk. Women who have HIV infection are cautioned against breast-feeding because of the risk of passing HIV to a baby who does not have the infection.

Children: The safety and effectiveness of Videx Ec have not been established for children.

Seniors: Seniors have an increased risk of side effects with didanosine. They may require lower doses and closer monitoring by the doctor.